The Food and Drug Administration and the Department of Homeland Security have issued alerts about cyber vulnerabilities in certain cardiac devices made by St. Jude Medical. The company, recently acquired by Abbott Laboratories, has issued software updates to address the problems.
An FDA spokeswoman says the devices at the center of the FDA alert are the same St. Jude cardiac products that were spotlighted as having cyber vulnerabilities in a controversial report issued last year by investment firm Muddy Waters Capital and start-up research firm MedSec Holdings (see Report on Cardiac Device Cyber Vulnerabilities Fuels Debate).
